Publications by authors named "Brigitte Tranchand"

Claim this Profile
P
Population pharmacokinetics and pharmacodynamics of cisplatinum during hyperthermic intraperitoneal chemotherapy using a closed abdominal procedure.
Eddy Cotte, Olivier Colomban, Jérome Guitton, Brigitte Tranchand, Nawel Bakrin

J Clin Pharmacol· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive value of modeled AUC(AFP-hCG), a dynamic kinetic parameter characterizing serum tumor marker decline in patients with nonseminomatous germ cell tumor.
Benoit You, Ludivine Fronton, Helen Boyle, Jean-Pierre Droz, Pascal Girard, Brigitte Tranchand

Urology· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetically based estimation of patient compliance with oral anticancer chemotherapies: in silico evaluation.
Emilie Hénin, Michel Tod, Véronique Trillet-Lenoir, Catherine Rioufol, Brigitte Tranchand

Clin Pharmacokinet· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Etoposide pharmacokinetics and survival in patients with small cell lung cancer: a multicentre study.
Benoit You, Brigitte Tranchand, Pascal Girard, Claire Falandry, Benjamin Ribba

Lung Cancer· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advantages of prostate-specific antigen (PSA) clearance model over simple PSA half-life computation to describe PSA decrease after prostate adenomectomy.
Benoit You, Paul Perrin, Gilles Freyer, Alain Ruffion, Brigitte Tranchand

Clin Biochem· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Pharmacology of anticancer drugs in the elderly: tools for dose-adjustment].
Brigitte Tranchand, Claire Falandry, Benoît You, Pascale Girard, Benjamin Ribba

Bull Cancer· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population pharmacokinetics and pharmacodynamics of doxorubicin and cyclophosphamide in breast cancer patients: a study by the EORTC-PAMM-NDDG.
Markus Joerger, Alwin D R Huitema, Dick J Richel, Christian Dittrich, Nikolas Pavlidis, Brigitte Tranchand

Clin Pharmacokinet· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population pharmacokinetics and pharmacodynamics of paclitaxel and carboplatin in ovarian cancer patients: a study by the European organization for research and treatment of cancer-pharmacology and molecular mechanisms group and new drug development group.
Markus Joerger, Alwin D R Huitema, Dick J Richel, Christian Dittrich, Nikolas Pavlidis, Brigitte Tranchand

Clin Cancer Res· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Issues of the study of patient compliance to treatment with oral anticancer chemotherapy: advantages of pharmacokinetics-pharmacodynamics modelisation].
Emilie Hénin, Benoit You, Brigitte Tranchand, Gilles Freyer, Pascal Girard

Therapie· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Contribution of modelling chemotherapy-induced hematological toxicity for clinical practice.
Diane Testart-Paillet, Pascal Girard, Benoit You, Gilles Freyer, Christian Pobel, Brigitte Tranchand

Crit Rev Oncol Hematol· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exposure-effect population model of inolimomab, a monoclonal antibody administered in first-line treatment for acute graft-versus-host disease.
Céline Dartois, Gilles Freyer, Mauricette Michallet, Emilie Hénin, Benoît You, Brigitte Tranchand

Clin Pharmacokinet· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of uncertainty parameters estimated by different population PK software and methods.
Céline Dartois, Annabelle Lemenuel-Diot, Christian Laveille, Brigitte Tranchand, Michel Tod

J Pharmacokinet Pharmacodyn· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
International Society of Geriatric Oncology Chemotherapy Taskforce: evaluation of chemotherapy in older patients--an analysis of the medical literature.
Stuart M Lichtman, Hans Wildiers, Etienne Chatelut, Christopher Steer, Daniel Budman, Brigitte Tranchand

J Clin Oncol· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Are population pharmacokinetic and/or pharmacodynamic models adequately evaluated? A survey of the literature from 2002 to 2004.
Karl Brendel, Céline Dartois, Emmanuelle Comets, Annabelle Lemenuel-Diot, Christian Laveille, Brigitte Tranchand

Clin Pharmacokinet· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic drug monitoring for dose individualization of Cisplatin in testicular cancer patients based upon total platinum measurement in plasma.
Sébastien Salas, Cédric Mercier, Joseph Ciccolini, Bertrand Pourroy, Raphaelle Fanciullino, Brigitte Tranchand

Ther Drug Monit· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dose individualization of carboplatin after a 120-hour infusion schedule: higher dose intensity but fewer toxicities.
Cédric Mercier, Joseph Ciccolini, Bertrand Pourroy, Raphaelle Fanciullino, Florence Duffaud, Brigitte Tranchand

Ther Drug Monit· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacology of cytotoxic agents: a helpful tool for building dose adjustment guidelines in the elderly.
Brigitte Tranchand, Silvy Laporte, Olivier Glehen, Gilles Freyer

Crit Rev Oncol Hematol· November 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intermediate-dose (25mg/m2) IV melphalan for multiple myeloma with renal failure.
Cécile Vigneau, Claude Ardiet, Monique Bret, Maurice Laville, Denis Fiere, Brigitte Tranchand

J Nephrol· March 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A simultaneous oral/intravenous population pharmacokinetic model for vinorelbine.
Philippe Variol, Laurent Nguyen, Brigitte Tranchand, Christian Puozzo

Eur J Clin Pharmacol· October 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population pharmacokinetics model and limited sampling strategy for intravenous vinorelbine derived from phase I clinical trials.
Laurent Nguyen, Brigitte Tranchand, Christian Puozzo, Philippe Variol

Br J Clin Pharmacol· May 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis